UPC_CFI_616/2025

LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY

InfringementMain Infringement ActionThe Hague LDInfringementWritten Phase

Overview Decisions Documents Timeline

Parties

Claimants

GlaxoSmithKline Biologicals SA

Reps: Tjibbe Douma

Respondents

Moderna Netherlands B.V.(Moderna Group)
Moderna Biotech Spain SL(Moderna Group)
Moderna Biotech UK Limited(Moderna Group)
Moderna Biotech Distributor UK Ltd(Moderna Group)
Moderna Switzerland GmbH(Moderna Group)
Moderna Poland SP. Z.O.O.(Moderna Group)
Moderna, Inc.(Moderna Group)
ModernaTX, Inc.(Moderna Group)
Moderna Belgium S.R.L.(Moderna Group)
Moderna France SASU(Moderna Group)
Moderna Germany GmbH(Moderna Group)
Moderna Italy S.R.L.(Moderna Group)
Moderna Portugal Unipessoal LDA(Moderna Group)
Moderna Sweden AB(Moderna Group)
Moderna Norway A/S(Moderna Group)

Judges

Edger Brinkman
Margot Kokke
Stefan Schilling
Martin Schmidt

Patents

EP2590626

CPC codes: A61K31/7088, A61K9/127, A61K39/39, A61P31/04, A61P35/00, C12N2760/18534, C12N2770/36134, Y02A50/30, A61K39/12, A61P31/12, A61P31/10, A61K2039/53…

Technology area: Biotech · mRNA

Sector: Biotechnology

Outcome

Procedural onlyProcedural only (no substantive ruling yet)

Filed: Nov 6, 2025

First decided: Feb 18, 2026

Language: English

Open on UPC Registry